Related Experiment Video
Updated: Jul 18, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo
Johan Garaude1, Seyma Cherni, Sandra Kaminski
1Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique-Unité Mixte de Recherche 5535, IFR 122, 1919 Route de Mende, 34293 Montpellier, France.
Abstract:
MAPK cascades play a central role in the cellular response to the environment. The pathway involving the MAPK ERK5 mediates growth factor- and stress-induced intracellular signaling that controls proliferation or survival depending upon the cell context. In this study, we show that reducing ERK5 levels with a specific small hairpin RNA 5 (shERK5) reduced cell viability, sensitized cells to death receptor-induced apoptosis, and blocked the palliative effects of phorbol ester in anti-Fas Ab-treated cells. shERK5 decreased nuclear accumulation of the NF-kappaB p65 subunit, and conversely, ectopic activation of ERK5 led to constitutive nuclear localization of p65 and increased its ability to trans activate specific reporter genes. Finally, the T lymphoma cell line EL-4, upon expression of shERK5, proliferated in vitro, but failed to induce s.c. tumors in mice. Our results suggest that ERK5 is essential for survival of leukemic T cells in vivo, and thus represents a promising target for therapeutic intervention in this type of malignancy.
Insights
Reducing ERK5 levels hinders leukemic T cell survival and tumor growth. This highlights ERK5 as a potential therapeutic target for T-cell malignancies, impacting cell viability and apoptosis.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Cancer research
Background:
- Mitogen-activated protein kinase (MAPK) cascades are crucial for cellular environmental responses.
- The MAPK ERK5 pathway regulates proliferation and survival based on cellular context.
- ERK5 signaling is implicated in growth factor and stress responses.
Purpose of the Study:
- To investigate the role of ERK5 in leukemic T cell survival and proliferation.
- To determine if ERK5 is a viable therapeutic target for T-cell malignancies.
Main Methods:
- Utilized small hairpin RNA targeting ERK5 (shERK5) to reduce ERK5 levels.
- Assessed cell viability, apoptosis, and NF-kappaB p65 subunit nuclear localization.
- Evaluated tumor formation in vivo using the EL-4 T lymphoma cell line.
Main Results:
- Reduced ERK5 levels decreased cell viability and increased sensitivity to apoptosis.
- shERK5 inhibited nuclear accumulation of NF-kappaB p65 and its transactivation.
- ERK5 activation promoted constitutive nuclear localization of p65.
- EL-4 cells with shERK5 proliferated in vitro but failed to form tumors in vivo.
Conclusions:
- ERK5 is essential for the survival of leukemic T cells in vivo.
- Targeting ERK5 may offer a promising therapeutic strategy for T-cell malignancies.
- ERK5 signaling influences NF-kappaB pathway activation, impacting cell fate.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Abnormal Proliferation

